Adipokines in Multiple Sclerosis Patients Are Related to Clinical and Radiological Measures

Overview

Journal J Neurol

Specialty Neurology

Date 2022 Dec 23

PMID 36562851

Authors

Floor C Loonstra

Kim F Falize

Lodewijk R J de Ruiter

Menno M Schoonheim

Eva M M Strijbis

Joep Killestein

Helga E de Vries

Bernard M J Uitdehaag

Merel Rijnsburger

Affiliations

Soon will be listed here.

Abstract

Background: An imbalance of adipokines, hormones secreted by white adipose tissue, is suggested to play a role in the immunopathology of multiple sclerosis (MS). In people with MS (PwMS) of the same age, we aimed to determine whether the adipokines adiponectin, leptin, and resistin are associated with MS disease severity. Furthermore, we aimed to investigate whether these adipokines mediate the association between body mass index (BMI) and MS disease severity.

Methods: Adiponectin, resistin, and leptin were determined in serum using ELISA. 288 PwMS and 125 healthy controls (HC) were included from the Project Y cohort, a population-based cross-sectional study of people with MS born in the Netherlands in 1966, and age and sex-matched HC. Adipokine levels and BMI were related to demographic, clinical and disability measures, and MRI-based brain volumes.

Results: Adiponectin levels were 1.2 fold higher in PwMS vs. HC, especially in secondary progressive MS. Furthermore, we found a sex-specific increase in adiponectin levels in primary progressive (PP) male patients compared to male controls. Leptin and resistin levels did not differ between PwMS and HC, however, leptin levels were associated with higher disability (EDSS) and resistin strongly related to brain volumes in progressive patients, especially in several grey matter regions in PPMS. Importantly, correction for BMI did not significantly change the results.

Conclusion: In PwMS of the same age, we found associations between adipokines (adiponectin, leptin, and resistin) and a range of clinical and radiological metrics. These associations were independent of BMI, indicating distinct mechanisms.

Citing Articles

Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis.

John N, Li Y, De Angelis F, Stutters J, Prados F, Doshi A Eur J Neurol. 2024; 32(1):e16586.

PMID: 39691073 PMC: 11653023. DOI: 10.1111/ene.16586.

Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue.

Mallardo M, Mazzeo F, Lus G, Signoriello E, Daniele A, Nigro E Nutrients. 2024; 16(18).

PMID: 39339700 PMC: 11434938. DOI: 10.3390/nu16183100.

Oral Contraceptives Interact with Adiposity-Associated Markers in Patients with Multiple Sclerosis.

Ferret-Sena V, Ramos C, Cascais M, Capela C, Sena A J Clin Med. 2024; 13(2).

PMID: 38256598 PMC: 10816152. DOI: 10.3390/jcm13020464.

References

Frommer K, Zimmermann B, Meier F, Schroder D, Heil M, Schaffler A . Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis Rheum. 2010; 62(10):2886-99. DOI: 10.1002/art.27616. View

Chatzantoni K, Papathanassopoulos P, Gourzoulidou E, Mouzaki A . Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS.... J Autoimmun. 2004; 23(2):169-77. DOI: 10.1016/j.jaut.2004.05.007. View

Coban A, DUzel B, Tuzun E, Tamam Y . Investigation of the prognostic value of adipokines in multiple sclerosis. Mult Scler Relat Disord. 2017; 15:11-14. DOI: 10.1016/j.msard.2017.04.006. View

Dashti M, Alroughani R, Jacob S, Al-Temaimi R . Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait. Mult Scler Relat Disord. 2019; 36:101409. DOI: 10.1016/j.msard.2019.101409. View

De Stefano N, Stromillo M, Giorgio A, Bartolozzi M, Battaglini M, Baldini M . Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015; 87(1):93-9. PMC: 4717444. DOI: 10.1136/jnnp-2014-309903. View

Mowry E, Azevedo C, McCulloch C, Okuda D, Lincoln R, Waubant E . Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. 2018; 91(24):e2256-e2264. PMC: 6329329. DOI: 10.1212/WNL.0000000000006644. View

Piccio L, Cantoni C, Henderson J, Hawiger D, Ramsbottom M, Mikesell R . Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. Eur J Immunol. 2013; 43(8):2089-100. PMC: 3901539. DOI: 10.1002/eji.201242836. View

Nicolas S, Cazareth J, Zarif H, Guyon A, Heurteaux C, Chabry J . Globular Adiponectin Limits Microglia Pro-Inflammatory Phenotype through an AdipoR1/NF-κB Signaling Pathway. Front Cell Neurosci. 2017; 11:352. PMC: 5694456. DOI: 10.3389/fncel.2017.00352. View

Luo Y, Liu M . Adiponectin: a versatile player of innate immunity. J Mol Cell Biol. 2016; 8(2):120-8. PMC: 4816149. DOI: 10.1093/jmcb/mjw012. View

10.

Tilg H, Moschen A . Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006; 6(10):772-83. DOI: 10.1038/nri1937. View

11.

Haltia L, Viljanen A, Parkkola R, Kemppainen N, Rinne J, Nuutila P . Brain white matter expansion in human obesity and the recovering effect of dieting. J Clin Endocrinol Metab. 2007; 92(8):3278-84. DOI: 10.1210/jc.2006-2495. View

12.

DUzel B, Tamam Y, Coban A, Tuzun E . Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation. Immunol Invest. 2018; 48(2):190-197. DOI: 10.1080/08820139.2018.1528270. View

13.

Pannacciulli N, Le D, Chen K, Reiman E, Krakoff J . Relationships between plasma leptin concentrations and human brain structure: a voxel-based morphometric study. Neurosci Lett. 2006; 412(3):248-53. PMC: 1828136. DOI: 10.1016/j.neulet.2006.11.019. View

14.

Lieb W, Beiser A, Vasan R, Tan Z, Au R, Harris T . Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009; 302(23):2565-72. PMC: 2838501. DOI: 10.1001/jama.2009.1836. View

15.

Emamgholipour S, Eshaghi S, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Sahraian M . Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease. PLoS One. 2013; 8(10):e76555. PMC: 3789814. DOI: 10.1371/journal.pone.0076555. View

16.

Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A . Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005; 174(9):5789-95. DOI: 10.4049/jimmunol.174.9.5789. View

17.

Parimisetty A, Dorsemans A, Awada R, Ravanan P, Diotel N, Lefebvre dHellencourt C . Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation. 2016; 13(1):67. PMC: 4806498. DOI: 10.1186/s12974-016-0530-x. View

18.

Esmaili S, Xu A, George J . The multifaceted and controversial immunometabolic actions of adiponectin. Trends Endocrinol Metab. 2014; 25(9):444-51. DOI: 10.1016/j.tem.2014.06.001. View

19.

Chen K, Lainez N, Coss D . Sex Differences in Macrophage Responses to Obesity-Mediated Changes Determine Migratory and Inflammatory Traits. J Immunol. 2020; 206(1):141-153. PMC: 8903060. DOI: 10.4049/jimmunol.2000490. View

20.

Mogilenko D, Shchukina I, Artyomov M . Immune ageing at single-cell resolution. Nat Rev Immunol. 2021; 22(8):484-498. PMC: 8609266. DOI: 10.1038/s41577-021-00646-4. View